drugset / Trial / NCT06355856

Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss

NCT06355856 ↗

Phase 4 Unknown 196 enrolled Ache Laboratorios Farmaceuticos S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evaluation of the efficacy and safety of DNN.22.17.036 versus 10573048700 in the treatment of male pattern hair loss.

Timeline

Start
2024-04
Primary completion
2025-05
Completion
2025-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator 10573048700 Unknown 1 ml Topical
Subject DNN.22.17.036 Unknown 1 ml Topical

Indications